Flow cytometric detection of p53 protein after incubation of a pre-B cell line with antitumor agents

Cytometry

Volumn 35, Issue 3, 1999, Pages 267-273

  Filippini, Giuditta ^a   Balmelli, Tiziano ^a   Eppenberger, Hans ^b   Soldati, Gianni ^a  

^a Laboratory of Molecular Diagnostics   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Antitumor agents; Apoptosis; Flow cytometric quantification; p53

Indexed keywords

ANTINEOPLASTIC AGENT; DISTAMYCIN A DERIVATIVE; DNA FRAGMENT; ETOPOSIDE; FCE 296; FCE 624; LIPOCORTIN 5; MELPHALAN; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033105046     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19990301)35:3<267::AID-CYTO10>3.0.CO;2-J     Document Type: Article

References (15)

1. Maltzaman W, Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 1984;4:1689-1694.
2. Fritsche M, Haessler C, Brandner G. Induction of nuclear accumulation of the tumor suppressor protein p53 by DNA damaging agents. Oncogene 1993;8:307-318.
3. Koeffler HP, Miller C, Nicolson MA. Ranyard J, Bosselman RA. Increased expression of p53 protein in human leukemia cells. Proc Natl Acad Sci USA 1986;83:4035-4039.
4. Chen TM, Defendi V. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells. Oncogene 1992;7:1541-1547.
5. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
6. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453-456.
7. Lowe SW, Bodis S, McClatchey A. Remington L, Earl Ruley H, Fisher DE, Housman DE, Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science 1994;266:807-810.
8. Lane DP. p53, guardian of the genome. Nature 1992;358:15-16.
9. Filippini G, Griffin S, Uhr M, Eppenberger HM, Bonilla J, Cavalli F. Soldati G. A novel flow cytometric method for the quantification of p53 gene expression. Cytometry 1998;31:180-186.
10. Andree HAM, Reutelingsperger CPM, Hauptman R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant α (VACα) to planar phospholipid bilayers. J Biol Chem 1990;265:1923.
11. Koopman G, Reutelingsperger CPM, Kuijten GAM. Keehnen RMJ, Pals ST, van Oers MHJ. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-1420.
12. Flaman JM, Frebourg T. Moreau V, Charbonnier F, Martin C, Chappuis P. Sappino AP, Limacher JM, Bron L, Benhatter J, Tada M, Van Meir EG, Estreicher A, Iggo RD. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 1995;92:3963-3967.
13. Lubbert M, Miller CW, Crawford L, Koeffler HP. p53 in chronic myelogenous leukemia. J Exp Med 1998;167:873-886.
14. Prokocimer M, Shaklai M, Bassat HB, Wolf D, Goldfinger N, Rotter V. Expression of p53 protein in human leukemia and lymphoma. Blood 1986;68:113-118.
15. Graniela Sirè EA, Vikhanskaya F, Broggini M. Sensitivity and cellular response to different anticancer agents of a human ovarian cancer cell line expressing wild-type, mutated or no p53. Ann Oncol 1995;6:589-593.